Check point inhibitor
Showing 51 - 75 of >10,000
Atherosclerosis, Cardiovascular Diseases Trial in Cambridge (Written Informed Consent, Inclusion/Exclusion check, Full Clinical
Completed
- Atherosclerosis
- Cardiovascular Diseases
- Written Informed Consent
- +16 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jan 7, 2020
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Hernia, Inguinal, Chronic Pain, Seroma Trial in Nanchong (Lightweight mesh fixation)
Recruiting
- Hernia, Inguinal
- +5 more
- Lightweight mesh fixation
-
Nanchong, Sichuan, ChinaYunhong Tian
Jun 30, 2023
NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)
Recruiting
- Non-Small Cell Lung Cancer
- Solid Tumor
- Atezolizumab
- +2 more
-
Fort Myers, Florida
- +6 more
Feb 16, 2022
Unresectable, Locally Advanced Or Metastatic Renal Cell
Completed
- Locally Advanced or Metastatic Renal Cell Carcinoma
- Cabozantinib monotherapy
- All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
-
The Woodlands, TexasMcKesson Life Sciences
Nov 11, 2021
AEBT Website With Check-ins, AEBT Website Without Check-ins Trial (Acceptance-Enhanced Behavior Therapy)
Not yet recruiting
- AEBT Website With Check-ins
- AEBT Website Without Check-ins
- Acceptance-Enhanced Behavior Therapy
- (no location specified)
Nov 8, 2022
Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- SGLT2 inhibitor
- Glimepiride
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Aug 1, 2023
Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,
Terminated
- Advanced Malignant Solid Neoplasm
- CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
- Placebo Administration
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 8, 2022
Burnout Trial in Portland (Supervisor-employee frequent check-ins to identify and address work stressors, Usual practice
Not yet recruiting
- Burnout
- Supervisor-employee frequent check-ins to identify and address work stressors
- Usual practice waitlist controls
-
Portland, OregonOHSU
Jun 27, 2022
Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)
Active, not recruiting
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Ravulizumab
-
Aurora, Colorado
- +19 more
Nov 16, 2022
Effect on HIV Medications on EPC Cells
Completed
- AIDS
- Tenofovir
- +3 more
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Mar 21, 2022
Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in
Completed
- Endometrial Endometrioid Adenocarcinoma
- +5 more
- Copanlisib
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +42 more
Jan 25, 2022
Club Foot Trial in Lahore (Low Dye Taping)
Recruiting
- Club Foot
- Low Dye Taping
-
Lahore, Punjab, PakistanChildren hospital
Mar 31, 2023
Teenagers and Non-histaminergic Angioedema With Normal C1
Not yet recruiting
- Hereditary Angioedema (HAE)
- Angioedema
- No Intervention
- (no location specified)
Jan 5, 2023
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Urin-based Point-of-Care Testing for Direct Oral Anticoagulants
Recruiting
- Stroke
- Urin-based test by the DOASENSE Dipstick Device
-
Gießen, Hesse, GermanyDepartment of Neurology, University Hospital Giessen
Sep 13, 2023
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Neoadjuvant Therapy
- 3cycles (Toripalimab + cetuximab)
- +2 more
-
Wuhan, Hebei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)
Not yet recruiting
- Diffuse Glioma
- Malignant Glioma
- Biospecimen Collection
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 6, 2023
A Survey of Darvadstrocel in People With Crohn's Disease
Recruiting
- Crohn's Disease
- Darvadstrocel
-
Tokyo, JapanTakeda selected site
Dec 5, 2022
PTSD Trial in Boston (LDAEP, Placebo, sertraline)
Recruiting
- Posttraumatic Stress Disorder
- LDAEP
- +2 more
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 9, 2022